A patent review of NLRP3 inhibitors to treat autoimmune diseases
.
Source: Expert Opinion on Therapeutic Patents - Category: Drugs & Pharmacology Authors: Yiming Xu Savannah Biby Baljit Kaur Shijun Zhang Source Type: research
More News: Autoimmune Disease | Drugs & Pharmacology